| (+)-alpha-viniferin | multiple interactions | ISO | RGD:1550709 | 6480464 | alpha-viniferin inhibits the reaction [IFNG protein results in increased expression of CXCL10 mRNA]; more ... | CTD | PMID:20424383 |
| (+)-catechin | multiple interactions | ISO | RGD:1352024 | 6480464 | Catechin inhibits the reaction [S100B protein results in increased expression of CXCL10 mRNA] | CTD | PMID:17103373 |
| (-)-epigallocatechin 3-gallate | multiple interactions | ISO | RGD:1352024 | 6480464 | [potassium chromate(VI) co-treated with epigallocatechin gallate] results in decreased expression of CXCL10 mRNA | CTD | PMID:22079256 |
| 1-chloro-2,4-dinitrobenzene | increases expression | ISO | RGD:1550709 | 6480464 | Dinitrochlorobenzene results in increased expression of CXCL10 mRNA | CTD | PMID:19647056 |
| 1-chloro-2,4-dinitrobenzene | increases expression | ISO | RGD:1352024 | 6480464 | Dinitrochlorobenzene results in increased expression of CXCL10 mRNA | CTD | PMID:20146380 |
| 1-fluoro-2,4-dinitrobenzene | increases expression | ISO | RGD:1550709 | 6480464 | Dinitrofluorobenzene results in increased expression of CXCL10 mRNA; more ... | CTD | PMID:15719370 |
| 1-O-(alpha-D-galactopyranosyl)-N-hexacosanoylphytosphingosine | increases expression | ISO | RGD:1352024 | 6480464 | KRN 7000 results in increased expression of CXCL10 protein | CTD | PMID:15867097 |
| 17alpha-ethynylestradiol | decreases expression | ISO | RGD:1550709 | 6480464 | Ethinyl Estradiol results in decreased expression of CXCL10 mRNA | CTD | PMID:15885639 |
| 17alpha-ethynylestradiol | multiple interactions | ISO | RGD:1550709 | 6480464 | [Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of CXCL10 mRNA | CTD | PMID:17942748 |
| 17beta-estradiol | increases expression | ISO | RGD:1352024 | 6480464 | Estradiol results in increased expression of CXCL10 mRNA; more ... | CTD | PMID:15557169 |
| 17beta-estradiol | multiple interactions | ISO | RGD:1352024 | 6480464 | [Progesterone co-treated with Estradiol] results in increased expression of CXCL10 mRNA | CTD | PMID:17404688 |
| 17beta-estradiol | multiple interactions | ISO | RGD:1352024 | 6480464 | fulvestrant inhibits the reaction [Estradiol results in increased expression of CXCL10 mRNA] | CTD | PMID:15557169 |
| 17beta-estradiol | multiple interactions | ISO | RGD:1550709 | 6480464 | Estradiol inhibits the reaction [lipopolysaccharide, E. coli 026-B6 results in increased expression of CXCL10 mRNA]; more ... | CTD | PMID:19533603 |
| 2,3,7,8-tetrachlorodibenzodioxine | decreases expression | ISO | RGD:1352024 | 6480464 | Tetrachlorodibenzodioxin results in decreased expression of CXCL10 mRNA | CTD | PMID:20106945 |
| 2,3,7,8-tetrachlorodibenzodioxine | increases expression | ISO | RGD:1550709 | 6480464 | Tetrachlorodibenzodioxin results in increased expression of CXCL10 mRNA | CTD | PMID:23238561 |
| 2,3,7,8-tetrachlorodibenzodioxine | increases expression | EXP | | 6480464 | Tetrachlorodibenzodioxin results in increased expression of CXCL10 mRNA | CTD | PMID:15644576 more ... |
| 2,3,7,8-tetrachlorodibenzodioxine | increases expression | EXP | | 6480464 | Tetrachlorodibenzodioxin results in increased expression of CXCL10 mRNA | CTD | PMID:15644576 more ... |
| 2,3,7,8-tetrachlorodibenzodioxine | affects expression | ISO | RGD:1352024 | 6480464 | Tetrachlorodibenzodioxin affects the expression of CXCL10 mRNA | CTD | PMID:22298810 |
| 2,3,7,8-tetrachlorodibenzodioxine | increases expression | EXP | | 6480464 | Tetrachlorodibenzodioxin results in increased expression of CXCL10 mRNA | CTD | PMID:15644576 PMID:21215274 |
| 2,3,7,8-tetrachlorodibenzodioxine | decreases expression | ISO | RGD:1550709 | 6480464 | Tetrachlorodibenzodioxin results in decreased expression of CXCL10 mRNA | CTD | PMID:19770486 |
| 2,3,7,8-tetrachlorodibenzodioxine | increases expression | EXP | | 6480464 | Tetrachlorodibenzodioxin results in increased expression of CXCL10 mRNA | CTD | PMID:15644576 |
| 2,3,7,8-tetrachlorodibenzodioxine | multiple interactions | ISO | RGD:1550709 | 6480464 | [Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of CXCL10 mRNA | CTD | PMID:17942748 |
| 2,4,6-trinitrotoluene | affects expression | EXP | | 6480464 | Trinitrotoluene affects the expression of CXCL10 mRNA | CTD | PMID:21346803 |
| 2,4-dinitrotoluene | affects expression | EXP | | 6480464 | 2,4-dinitrotoluene affects the expression of CXCL10 mRNA | CTD | PMID:21346803 |
| 2,6-dichloroindophenol | multiple interactions | ISO | RGD:1352024 | 6480464 | [2,6-Dichloroindophenol co-treated with NQO1 protein polymorphism] results in increased expression of CXCL10 mRNA | CTD | PMID:21034357 |
| 2-amino-2-deoxy-D-glucopyranose | multiple interactions | ISO | RGD:1550709 | 6480464 | Glucosamine inhibits the reaction [Lipopolysaccharides results in increased expression of CXCL10 mRNA] | CTD | PMID:20737476 |
| 2-amino-2-deoxy-D-glucopyranose | multiple interactions | EXP | | 6480464 | Glucosamine inhibits the reaction [IL1B results in increased expression of CXCL10 mRNA] | CTD | PMID:17109745 |
| 2-nitrofluorene | increases expression | EXP | | 6480464 | 2-nitrofluorene results in increased expression of CXCL10 mRNA | CTD | PMID:14600272 PMID:15890375 |
| 2-nitrofluorene | increases expression | EXP | | 6480464 | 2-nitrofluorene results in increased expression of CXCL10 mRNA | CTD | PMID:15890375 PMID:14600272 |
| 3,3',4,4',5-pentachlorobiphenyl | decreases expression | ISO | RGD:1352024 | 6480464 | 3,4,5,3',4'-pentachlorobiphenyl results in decreased expression of CXCL10 mRNA | CTD | PMID:23146750 |
| 4-(ethoxymethylene)-2-phenyloxazol-5-one | increases expression | EXP | | 6480464 | Oxazolone results in increased expression of CXCL10 mRNA | CTD | PMID:21893156 |
| 4-(ethoxymethylene)-2-phenyloxazol-5-one | increases expression | ISO | RGD:1550709 | 6480464 | Oxazolone results in increased expression of CXCL10 mRNA | CTD | PMID:19647056 |
| 4-(N-nitrosomethylamino)-1-(3-pyridyl)butan-1-one | increases expression | EXP | | 6480464 | 4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone results in increased expression of CXCL10 mRNA | CTD | PMID:14600272 PMID:15890375 |
| 4-(N-nitrosomethylamino)-1-(3-pyridyl)butan-1-one | increases expression | EXP | | 6480464 | 4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone results in increased expression of CXCL10 mRNA | CTD | PMID:15890375 PMID:14600272 |
| 4-hydroxynon-2-enal | multiple interactions | ISO | RGD:1550709 | 6480464 | 4-hydroxy-2-nonenal inhibits the reaction [Lipopolysaccharides results in increased expression of CXCL10 mRNA]; more ... | CTD | PMID:19627980 |
| 4-nitroquinoline N-oxide | decreases expression | ISO | RGD:1550709 | 6480464 | 4-Nitroquinoline-1-oxide results in decreased expression of CXCL10 mRNA | CTD | PMID:22561872 |
| 4-nitroquinoline N-oxide | increases expression | ISO | RGD:1550709 | 6480464 | 4-Nitroquinoline-1-oxide results in increased expression of CXCL10 mRNA | CTD | PMID:22561872 |
| 5-aza-2'-deoxycytidine | affects methylation | ISO | RGD:1352024 | 6480464 | decitabine affects the methylation of CXCL10 promoter | CTD | PMID:17488656 |
| 8-bromo-3',5'-cyclic AMP | increases expression | ISO | RGD:1352024 | 6480464 | 8-Bromo Cyclic Adenosine Monophosphate results in increased expression of CXCL10 mRNA | CTD | PMID:22079614 |
| acrolein | multiple interactions | ISO | RGD:1550709 | 6480464 | CD8A gene mutant form inhibits the reaction [Acrolein results in increased expression of CXCL10 mRNA] | CTD | PMID:17950725 |
| acrolein | increases expression | ISO | RGD:1550709 | 6480464 | Acrolein results in increased expression of CXCL10 mRNA | CTD | PMID:17950725 |
| aflatoxin B1 | affects expression | ISO | RGD:1352024 | 6480464 | Aflatoxin B1 affects the expression of CXCL10 protein | CTD | PMID:20106945 |
| aflatoxin B1 | increases expression | EXP | | 6480464 | Aflatoxin B1 results in increased expression of CXCL10 mRNA | CTD | PMID:15890375 |
| aldehydo-D-glucosamine | multiple interactions | ISO | RGD:1550709 | 6480464 | Glucosamine inhibits the reaction [Lipopolysaccharides results in increased expression of CXCL10 mRNA] | CTD | PMID:20737476 |
| aldehydo-D-glucosamine | multiple interactions | EXP | | 6480464 | Glucosamine inhibits the reaction [IL1B results in increased expression of CXCL10 mRNA] | CTD | PMID:17109745 |
| all-trans-retinoic acid | decreases expression | ISO | RGD:1550709 | 6480464 | Tretinoin results in decreased expression of CXCL10 mRNA | CTD | PMID:16604517 |
| allopurinol | multiple interactions | ISO | RGD:1352024 | 6480464 | Allopurinol inhibits the reaction [vanadium pentoxide results in increased expression of CXCL10 mRNA] | CTD | PMID:18322232 |
| aluminium hydroxide | multiple interactions | ISO | RGD:1352024 | 6480464 | [Aluminum Hydroxide co-treated with Magnesium Hydroxide] inhibits the reaction [K-12 lipopolysaccharide results in increased secretion of CXCL10 protein] | CTD | PMID:17404311 |
| ammonium chloride | affects expression | EXP | | 6480464 | Ammonium Chloride affects the expression of CXCL10 mRNA | CTD | PMID:16483693 |
| apocynin | multiple interactions | ISO | RGD:1352024 | 6480464 | acetovanillone inhibits the reaction [vanadium pentoxide results in increased expression of CXCL10 mRNA] | CTD | PMID:18322232 |
| apocynin | multiple interactions | ISO | RGD:1352024 | 6480464 | acetovanillone inhibits the reaction [TNF protein results in increased expression of CXCL10 mRNA] | CTD | PMID:22414048 |
| benzo[a]pyrene | increases expression | ISO | RGD:1352024 | 6480464 | Benzo(a)pyrene results in increased expression of CXCL10 mRNA | CTD | PMID:19152381 |
| benzo[a]pyrene | multiple interactions | ISO | RGD:1550709 | 6480464 | AHR protein affects the reaction [Benzo(a)pyrene affects the expression of CXCL10 mRNA] | CTD | PMID:22228805 |
| benzo[a]pyrene | increases expression | EXP | | 6480464 | Benzo(a)pyrene results in increased expression of CXCL10 mRNA | CTD | PMID:21839799 |
| benzo[a]pyrene | multiple interactions | ISO | RGD:1352024 | 6480464 | chlorophyllin inhibits the reaction [Benzo(a)pyrene results in increased expression of CXCL10 mRNA] | CTD | PMID:19152381 |
| beta-D-glucosamine | multiple interactions | ISO | RGD:1550709 | 6480464 | Glucosamine inhibits the reaction [Lipopolysaccharides results in increased expression of CXCL10 mRNA] | CTD | PMID:20737476 |
| beta-D-glucosamine | multiple interactions | EXP | | 6480464 | Glucosamine inhibits the reaction [IL1B results in increased expression of CXCL10 mRNA] | CTD | PMID:17109745 |
| bilirubin | increases expression | ISO | RGD:1352024 | 6480464 | Bilirubin results in increased expression of CXCL10 mRNA | CTD | PMID:20196124 |
| bisphenol A | increases expression | EXP | | 6480464 | bisphenol A results in increased expression of CXCL10 mRNA | CTD | PMID:18180321 PMID:17010207 |
| bisphenol A | increases expression | EXP | | 6480464 | bisphenol A results in increased expression of CXCL10 mRNA | CTD | PMID:17010207 PMID:18180321 |
| cadmium dichloride | decreases methylation | EXP | | 6480464 | Cadmium Chloride results in decreased methylation of CXCL10 promoter | CTD | PMID:22457795 |
| capsaicin | increases expression | EXP | | 6480464 | Capsaicin results in increased expression of CXCL10 protein | CTD | PMID:22150557 |
| capsaicin | multiple interactions | EXP | | 6480464 | [Naproxen co-treated with Sumatriptan] inhibits the reaction [Capsaicin results in increased expression of CXCL10 protein]; more ... | CTD | PMID:22150557 |
| cefaloridine | increases expression | EXP | | 6480464 | Cephaloridine results in increased expression of CXCL10 mRNA | CTD | PMID:18500788 |
| chenodeoxycholic acid | increases expression | ISO | RGD:1550709 | 6480464 | Chenodeoxycholic Acid results in increased expression of CXCL10 mRNA | CTD | PMID:21224055 |
| ciguatoxin CTX1B | affects expression | ISO | RGD:1550709 | 6480464 | Ciguatoxins affects the expression of CXCL10 mRNA | CTD | PMID:18353800 |
| cisplatin | increases expression | ISO | RGD:1550709 | 6480464 | Cisplatin results in increased expression of CXCL10 mRNA | CTD | PMID:15814532 |
| cisplatin | increases expression | EXP | | 6480464 | Cisplatin results in increased expression of CXCL10 mRNA | CTD | PMID:22023808 |
| cobalt atom | multiple interactions | ISO | RGD:1550709 | 6480464 | [Organometallic Compounds co-treated with Cobalt] results in increased expression of CXCL10 mRNA | CTD | PMID:22147119 |
| cobalt atom | increases expression | ISO | RGD:1550709 | 6480464 | Cobalt results in increased expression of CXCL10 mRNA | CTD | PMID:22147119 |
| cocaine | increases secretion | ISO | RGD:1352024 | 6480464 | Cocaine results in increased secretion of CXCL10 protein | CTD | PMID:10065903 |
| copper(2+) sulfate | decreases expression | ISO | RGD:1352024 | 6480464 | Copper Sulfate results in decreased expression of CXCL10 mRNA | CTD | PMID:19549813 |
| cyclophosphamide | affects expression | ISO | RGD:1550709 | 6480464 | Cyclophosphamide affects the expression of CXCL10 mRNA | CTD | PMID:18957084 |
| cyclophosphamide | increases expression | ISO | RGD:1550709 | 6480464 | Cyclophosphamide results in increased expression of CXCL10 protein | CTD | PMID:18957084 |
| cyclophosphamide | increases response to substance | ISO | RGD:1550709 | 6480464 | CXCL10 protein results in increased susceptibility to Cyclophosphamide | CTD | PMID:18957084 |
| cyclosporin A | decreases expression | ISO | RGD:1352024 | 6480464 | Cyclosporine results in decreased expression of CXCL10 mRNA | CTD | PMID:20106945 |
| cyclosporin A | increases expression | ISO | RGD:1550709 | 6480464 | Cyclosporine results in increased expression of CXCL10 mRNA | CTD | PMID:19770486 |
| cyclosporin A | increases expression | EXP | | 6480464 | Cyclosporine results in increased expression of CXCL10 mRNA | CTD | PMID:21865292 |
| D-glucose | increases expression | ISO | RGD:1550709 | 6480464 | Glucose results in increased expression of CXCL10 mRNA | CTD | PMID:17178593 |
| dasatinib (anhydrous) | decreases expression | ISO | RGD:1352024 | 6480464 | dasatinib results in decreased expression of CXCL10 protein | CTD | PMID:17962511 |
| Delta(9)-tetrahydrocannabinol | increases expression | EXP | | 6480464 | Tetrahydrocannabinol results in increased expression of CXCL10 mRNA | CTD | PMID:16616335 |
| deoxycholic acid | increases expression | ISO | RGD:1550709 | 6480464 | Deoxycholic Acid results in increased expression of CXCL10 mRNA | CTD | PMID:21224055 |
| dexamethasone | increases expression | ISO | RGD:1550709 | 6480464 | Dexamethasone results in increased expression of CXCL10 mRNA | CTD | PMID:21041162 |
| diarsenic trioxide | increases expression | ISO | RGD:1352024 | 6480464 | arsenic trioxide results in increased expression of CXCL10 mRNA | CTD | PMID:17530438 |
| dibutyl phthalate | increases expression | ISO | RGD:1550709 | 6480464 | Dibutyl Phthalate results in increased expression of CXCL10 mRNA | CTD | PMID:21266533 |
| dibutyl phthalate | increases expression | ISO | RGD:1550709 | 6480464 | Dibutyl Phthalate results in increased expression of CXCL10 mRNA | CTD | PMID:17361019 PMID:21266533 |
| dibutyl phthalate | increases expression | EXP | | 6480464 | Dibutyl Phthalate results in increased expression of CXCL10 mRNA | CTD | PMID:21266533 |
| dichlorine | decreases expression | EXP | | 6480464 | Chlorine results in decreased expression of CXCL10 mRNA | CTD | PMID:18636392 |
| dichlorine | multiple interactions | EXP | | 6480464 | [Ozone co-treated with Chlorine] results in increased expression of CXCL10 mRNA | CTD | PMID:18636392 |
| diethyl maleate | decreases expression | EXP | | 6480464 | diethyl maleate results in decreased expression of CXCL10 mRNA | CTD | PMID:21161181 |
| diethylstilbestrol | increases expression | EXP | | 6480464 | Diethylstilbestrol results in increased expression of CXCL10 mRNA | CTD | PMID:15890375 |
| diethylstilbestrol | decreases expression | EXP | | 6480464 | Diethylstilbestrol results in decreased expression of CXCL10 mRNA | CTD | PMID:21658437 |
| divanadium pentaoxide | multiple interactions | ISO | RGD:1352024 | 6480464 | Allopurinol inhibits the reaction [vanadium pentoxide results in increased expression of CXCL10 mRNA]; more ... | CTD | PMID:18322232 |
| divanadium pentaoxide | increases expression | ISO | RGD:1352024 | 6480464 | vanadium pentoxide results in increased expression of CXCL10 mRNA | CTD | PMID:18322232 PMID:17459161 |
| divanadium pentaoxide | increases expression | ISO | RGD:1352024 | 6480464 | vanadium pentoxide results in increased expression of CXCL10 mRNA | CTD | PMID:17459161 PMID:18322232 |
| eriodictyol | multiple interactions | ISO | RGD:1550709 | 6480464 | eriodictyol inhibits the reaction [Lipopolysaccharides results in increased expression of CXCL10 mRNA]; more ... | CTD | PMID:19426678 |
| ethanol | multiple interactions | ISO | RGD:1550709 | 6480464 | Ethanol promotes the reaction [Lipopolysaccharides results in increased expression of CXCL10 protein]; more ... | CTD | PMID:20861358 |
| ethanol | multiple interactions | EXP | | 6480464 | Ethanol promotes the reaction [Lipopolysaccharides results in increased expression of CXCL10 mRNA]; more ... | CTD | PMID:20861358 |
| ethylene glycol bis(2-aminoethyl)tetraacetic acid | multiple interactions | ISO | RGD:1352024 | 6480464 | Egtazic Acid inhibits the reaction [Vehicle Emissions results in increased secretion of CXCL10 protein] | CTD | PMID:21245013 |
| fluoxetine | decreases secretion | ISO | RGD:1550709 | 6480464 | Fluoxetine results in decreased secretion of CXCL10 protein | CTD | PMID:21083617 |
| fulvestrant | multiple interactions | ISO | RGD:1352024 | 6480464 | fulvestrant inhibits the reaction [Estradiol results in increased expression of CXCL10 mRNA] | CTD | PMID:15557169 |
| fulvestrant | multiple interactions | ISO | RGD:1550709 | 6480464 | fulvestrant inhibits the reaction [2-(4-(4-chloro-1,2-diphenyl-but-1-enyl)phenoxy)ethanol inhibits the reaction [lipopolysaccharide, E. coli 026-B6 results in increased expression of CXCL10 mRNA]]; more ... | CTD | PMID:19533603 |
| furan | decreases expression | EXP | | 6480464 | furan results in decreased expression of CXCL10 mRNA | CTD | PMID:15120968 |
| furan | increases expression | ISO | RGD:1550709 | 6480464 | furan results in increased expression of CXCL10 mRNA | CTD | PMID:20194422 |
| gadodiamide hydrate | increases secretion | ISO | RGD:1352024 | 6480464 | gadodiamide results in increased secretion of CXCL10 protein | CTD | PMID:20959327 |
| gadodiamide hydrate | increases expression | ISO | RGD:1352024 | 6480464 | gadodiamide results in increased expression of CXCL10 mRNA | CTD | PMID:20959327 |
| gadodiamide hydrate | increases expression | EXP | | 6480464 | gadodiamide results in increased expression of CXCL10 protein | CTD | PMID:20938346 |
| genistein | increases expression | EXP | | 6480464 | Genistein results in increased expression of CXCL10 mRNA | CTD | PMID:17010207 |
| genistein | multiple interactions | EXP | | 6480464 | [Genistein co-treated with Methoxychlor] results in decreased expression of CXCL10 mRNA | CTD | PMID:21782745 |
| glucose | increases expression | ISO | RGD:1550709 | 6480464 | Glucose results in increased expression of CXCL10 mRNA | CTD | PMID:17178593 |
| gold atom | increases secretion | ISO | RGD:1550709 | 6480464 | Gold results in increased secretion of CXCL10 protein | CTD | PMID:22155353 |
| gold atom | multiple interactions | ISO | RGD:1550709 | 6480464 | [Gold co-treated with Silicon Dioxide] results in increased secretion of CXCL10 protein | CTD | PMID:22155353 |
| gold(0) | increases secretion | ISO | RGD:1550709 | 6480464 | Gold results in increased secretion of CXCL10 protein | CTD | PMID:22155353 |
| gold(0) | multiple interactions | ISO | RGD:1550709 | 6480464 | [Gold co-treated with Silicon Dioxide] results in increased secretion of CXCL10 protein | CTD | PMID:22155353 |
| halothane | decreases expression | EXP | | 6480464 | Halothane results in decreased expression of CXCL10 mRNA | CTD | PMID:15564938 |
| heparan sulfate | multiple interactions | ISO | RGD:1352024 | 6480464 | CXCL10 protein inhibits the reaction [CXCL1 protein binds to Heparitin Sulfate] | CTD | PMID:12549928 |
| hexachlorobenzene | affects expression | EXP | | 6480464 | Hexachlorobenzene affects the expression of CXCL10 mRNA | CTD | PMID:15159207 |
| ibuprofen | multiple interactions | ISO | RGD:1352024 | 6480464 | Ibuprofen inhibits the reaction [Lipopolysaccharides results in increased expression of CXCL10 protein] | CTD | PMID:19020770 |
| imatinib | multiple interactions | ISO | RGD:1352024 | 6480464 | imatinib inhibits the reaction [[IL1B protein co-treated with IFNG protein] results in increased secretion of CXCL10 protein] | CTD | PMID:21935477 |
| indomethacin | multiple interactions | ISO | RGD:1352024 | 6480464 | Dinoprostone inhibits the reaction [Indomethacin inhibits the reaction [Roflumilast inhibits the reaction [Lipopolysaccharides results in increased secretion of CXCL10 protein]]] | CTD | PMID:21913898 |
| isoflurane | decreases expression | EXP | | 6480464 | Isoflurane results in decreased expression of CXCL10 mRNA | CTD | PMID:15564938 |
| isotretinoin | decreases expression | ISO | RGD:1352024 | 6480464 | Isotretinoin results in decreased expression of CXCL10 mRNA | CTD | PMID:15972972 |
| isotretinoin | decreases expression | EXP | | 6480464 | Isotretinoin results in decreased expression of CXCL10 mRNA | CTD | PMID:15972972 |
| L-ascorbic acid | decreases expression | ISO | RGD:1352024 | 6480464 | Ascorbic Acid results in decreased expression of CXCL10 mRNA | CTD | PMID:19932582 |
| L-ascorbic acid | increases expression | ISO | RGD:1352024 | 6480464 | Ascorbic Acid deficiency results in increased expression of CXCL10 mRNA | CTD | PMID:19932582 |
| leptomycin B | decreases secretion | ISO | RGD:1352024 | 6480464 | leptomycin B results in decreased secretion of CXCL10 protein | CTD | PMID:21967610 |
| leptomycin B | multiple interactions | ISO | RGD:1352024 | 6480464 | acteoside promotes the reaction [leptomycin B results in decreased secretion of CXCL10 protein]; more ... | CTD | PMID:21967610 |
| levonorgestrel | multiple interactions | ISO | RGD:1352024 | 6480464 | [testosterone undecanoate co-treated with Levonorgestrel] results in increased expression of CXCL10 mRNA | CTD | PMID:19074003 |
| lucanthone | increases expression | ISO | RGD:1352024 | 6480464 | Lucanthone results in increased expression of CXCL10 mRNA | CTD | PMID:21148553 |
| luteolin | multiple interactions | ISO | RGD:1550709 | 6480464 | Luteolin inhibits the reaction [Lipopolysaccharides results in increased expression of CXCL10 mRNA]; more ... | CTD | PMID:19426678 |
| magnesium dihydroxide | multiple interactions | ISO | RGD:1352024 | 6480464 | [Aluminum Hydroxide co-treated with Magnesium Hydroxide] inhibits the reaction [K-12 lipopolysaccharide results in increased secretion of CXCL10 protein] | CTD | PMID:17404311 |
| melatonin | multiple interactions | ISO | RGD:1550709 | 6480464 | [Lipopolysaccharides co-treated with Melatonin] results in decreased expression of CXCL10 mRNA; more ... | CTD | PMID:21461237 |
| melatonin | decreases expression | ISO | RGD:1550709 | 6480464 | Melatonin results in decreased expression of CXCL10 mRNA | CTD | PMID:21461237 |
| methapyrilene | increases expression | EXP | | 6480464 | Methapyrilene results in increased expression of CXCL10 mRNA | CTD | PMID:15890375 |
| methotrexate | affects expression | ISO | RGD:1550709 | 6480464 | Methotrexate affects the expression of CXCL10 mRNA | CTD | PMID:18502557 |
| methotrexate | decreases expression | EXP | | 6480464 | Methotrexate results in decreased expression of CXCL10 mRNA | CTD | PMID:15120968 |
| methoxychlor | multiple interactions | EXP | | 6480464 | [Genistein co-treated with Methoxychlor] results in decreased expression of CXCL10 mRNA | CTD | PMID:21782745 |
| mono(2-ethylhexyl) phthalate | increases expression | EXP | | 6480464 | mono-(2-ethylhexyl)phthalate results in increased expression of CXCL10 mRNA | CTD | PMID:16809437 |
| monocrotaline | multiple interactions | ISO | RGD:1550709 | 6480464 | [Monocrotaline co-treated with Rifampin co-treated with Phenytoin co-treated with PRKDC] results in increased expression of CXCL10 mRNA | CTD | PMID:21224054 |
| N-nitrosodimethylamine | increases expression | EXP | | 6480464 | Dimethylnitrosamine results in increased expression of CXCL10 mRNA | CTD | PMID:14600272 PMID:15890375 |
| N-nitrosodimethylamine | increases expression | EXP | | 6480464 | Dimethylnitrosamine results in increased expression of CXCL10 mRNA | CTD | PMID:15890375 PMID:14600272 |
| naphthalene | increases expression | ISO | RGD:1550709 | 6480464 | naphthalene results in increased expression of CXCL10 mRNA | CTD | PMID:18978301 |
| naproxen | multiple interactions | EXP | | 6480464 | [Naproxen co-treated with Sumatriptan] inhibits the reaction [Capsaicin results in increased expression of CXCL10 protein]; more ... | CTD | PMID:22150557 |
| nickel sulfate | multiple interactions | ISO | RGD:1352024 | 6480464 | nickel sulfate inhibits the reaction [macrophage stimulatory lipopeptide 2 results in increased expression of CXCL10 mRNA]; more ... | CTD | PMID:18832182 |
| nickel sulfate | multiple interactions | ISO | RGD:1352024 | 6480464 | nickel sulfate inhibits the reaction [macrophage stimulatory lipopeptide 2 results in increased expression of CXCL10 mRNA] | CTD | PMID:18096868 PMID:18832182 |
| nickel sulfate | increases expression | ISO | RGD:1352024 | 6480464 | nickel sulfate results in increased expression of CXCL10 mRNA | CTD | PMID:12060402 |
| nickel sulfate | multiple interactions | ISO | RGD:1352024 | 6480464 | nickel sulfate inhibits the reaction [macrophage stimulatory lipopeptide 2 results in increased expression of CXCL10 mRNA] | CTD | PMID:18832182 PMID:18096868 |
| nickel sulfate | multiple interactions | ISO | RGD:1352024 | 6480464 | N-(2-cyclohexyloxy-4-nitrophenyl)methanesulfonamide inhibits the reaction [nickel sulfate inhibits the reaction [macrophage stimulatory lipopeptide 2 results in increased secretion of CXCL10 protein]] | CTD | PMID:18096868 |
| nimesulide | multiple interactions | ISO | RGD:1550709 | 6480464 | [nimesulide results in decreased activity of PTGS2 protein] which results in increased expression of CXCL10 mRNA | CTD | PMID:22561872 |
| nitric oxide | decreases secretion | ISO | RGD:1352024 | 6480464 | Nitric Oxide results in decreased secretion of CXCL10 protein | CTD | PMID:13678430 |
| NS-398 | multiple interactions | ISO | RGD:1352024 | 6480464 | N-(2-cyclohexyloxy-4-nitrophenyl)methanesulfonamide inhibits the reaction [nickel sulfate inhibits the reaction [macrophage stimulatory lipopeptide 2 results in increased secretion of CXCL10 protein]] | CTD | PMID:18096868 |
| ozone | multiple interactions | ISO | RGD:1550709 | 6480464 | IL1R1 gene mutant form inhibits the reaction [Ozone results in increased expression of CXCL10 protein] | CTD | PMID:17575079 |
| ozone | increases expression | ISO | RGD:1550709 | 6480464 | Ozone results in increased expression of CXCL10 protein | CTD | PMID:17575079 PMID:11777981 |
| ozone | multiple interactions | EXP | | 6480464 | [Ozone co-treated with Chlorine] results in increased expression of CXCL10 mRNA | CTD | PMID:18636392 |
| ozone | increases response to substance | ISO | RGD:1550709 | 6480464 | CXCL10 protein results in increased susceptibility to Ozone | CTD | PMID:11777981 |
| ozone | increases expression | ISO | RGD:1550709 | 6480464 | Ozone results in increased expression of CXCL10 mRNA | CTD | PMID:11777981 |
| ozone | increases expression | ISO | RGD:1550709 | 6480464 | Ozone results in increased expression of CXCL10 protein | CTD | PMID:11777981 PMID:17575079 |
| paclitaxel | increases expression | ISO | RGD:1550709 | 6480464 | Paclitaxel results in increased expression of CXCL10 mRNA | CTD | PMID:11123339 |
| paclitaxel | multiple interactions | ISO | RGD:1550709 | 6480464 | TLR4 protein affects the reaction [Paclitaxel results in increased expression of CXCL10 mRNA] | CTD | PMID:11123339 |
| paracetamol | increases expression | ISO | RGD:1550709 | 6480464 | Acetaminophen results in increased expression of CXCL10 mRNA | CTD | PMID:15578514 more ... |
| paracetamol | increases expression | ISO | RGD:1550709 | 6480464 | Acetaminophen results in increased expression of CXCL10 mRNA | CTD | PMID:12153990 more ... |
| paracetamol | decreases expression | ISO | RGD:1352024 | 6480464 | Acetaminophen results in decreased expression of CXCL10 mRNA | CTD | PMID:21420995 |
| paracetamol | increases expression | ISO | RGD:1550709 | 6480464 | Acetaminophen results in increased expression of CXCL10 mRNA | CTD | PMID:12153990 more ... |
| paracetamol | increases expression | ISO | RGD:1550709 | 6480464 | Acetaminophen results in increased expression of CXCL10 mRNA | CTD | PMID:18544908 more ... |
| paracetamol | decreases expression | EXP | | 6480464 | Acetaminophen results in decreased expression of CXCL10 mRNA | CTD | PMID:15120968 |
| paracetamol | multiple interactions | ISO | RGD:1550709 | 6480464 | IFNG protein promotes the reaction [Acetaminophen results in increased expression of CXCL10 mRNA] | CTD | PMID:12153990 |
| paracetamol | multiple interactions | ISO | RGD:1550709 | 6480464 | KLRB1C protein promotes the reaction [Acetaminophen results in increased expression of CXCL10 mRNA] | CTD | PMID:15578514 |
| paracetamol | increases expression | ISO | RGD:1550709 | 6480464 | Acetaminophen results in increased expression of CXCL10 protein; more ... | CTD | PMID:11739529 |
| paracetamol | increases expression | ISO | RGD:1550709 | 6480464 | Acetaminophen results in increased expression of CXCL10 mRNA | CTD | PMID:15578514 more ... |
| paracetamol | affects expression | ISO | RGD:1550709 | 6480464 | Acetaminophen affects the expression of CXCL10 mRNA | CTD | PMID:17562736 |
| paraquat | increases expression | ISO | RGD:1352024 | 6480464 | Paraquat results in increased expression of CXCL10 mRNA | CTD | PMID:22230393 |
| phenethyl isothiocyanate | multiple interactions | ISO | RGD:1550709 | 6480464 | phenethyl isothiocyanate inhibits the reaction [Lipopolysaccharides results in increased expression of CXCL10 mRNA] | CTD | PMID:20423518 |
| phenobarbital | multiple interactions | ISO | RGD:1550709 | 6480464 | NR1I3 protein affects the reaction [Phenobarbital results in increased expression of CXCL10 mRNA] | CTD | PMID:19482888 |
| phenobarbital | affects expression | ISO | RGD:1550709 | 6480464 | Phenobarbital affects the expression of CXCL10 mRNA | CTD | PMID:23091169 |
| phenobarbital | increases expression | ISO | RGD:1550709 | 6480464 | Phenobarbital results in increased expression of CXCL10 mRNA | CTD | PMID:19482888 |
| phenylephrine | decreases expression | EXP | | 6480464 | Phenylephrine results in decreased expression of CXCL10 mRNA | CTD | PMID:18158353 |
| phenytoin | multiple interactions | ISO | RGD:1550709 | 6480464 | [Monocrotaline co-treated with Rifampin co-treated with Phenytoin co-treated with PRKDC] results in increased expression of CXCL10 mRNA | CTD | PMID:21224054 |
| phorbol 13-acetate 12-myristate | decreases expression | ISO | RGD:1550709 | 6480464 | Tetradecanoylphorbol Acetate results in decreased expression of CXCL10 mRNA | CTD | PMID:22359662 |
| phorbol 13-acetate 12-myristate | multiple interactions | ISO | RGD:1550709 | 6480464 | IL17RA gene mutant form inhibits the reaction [Tetradecanoylphorbol Acetate results in decreased expression of CXCL10 mRNA] | CTD | PMID:22359662 |
| piperonyl butoxide | increases expression | EXP | | 6480464 | Piperonyl Butoxide results in increased expression of CXCL10 mRNA | CTD | PMID:15890375 |
| pirinixic acid | increases expression | EXP | | 6480464 | pirinixic acid results in increased expression of CXCL10 mRNA | CTD | PMID:15890375 |
| progesterone | multiple interactions | ISO | RGD:1352024 | 6480464 | [Progesterone co-treated with Estradiol] results in increased expression of CXCL10 mRNA | CTD | PMID:17404688 |
| progesterone | increases expression | ISO | RGD:1352024 | 6480464 | Progesterone results in increased expression of CXCL10 mRNA | CTD | PMID:15557169 |
| propiconazole | increases expression | ISO | RGD:1550709 | 6480464 | propiconazole results in increased expression of CXCL10 mRNA | CTD | PMID:21278054 |
| prostaglandin E2 | multiple interactions | ISO | RGD:1352024 | 6480464 | Dinoprostone inhibits the reaction [Indomethacin inhibits the reaction [Roflumilast inhibits the reaction [Lipopolysaccharides results in increased secretion of CXCL10 protein]]]; more ... | CTD | PMID:21913898 |
| quercetin | multiple interactions | ISO | RGD:1550709 | 6480464 | Quercetin inhibits the reaction [Lipopolysaccharides results in increased expression of CXCL10 mRNA]; more ... | CTD | PMID:19426678 |
| quercetin | multiple interactions | ISO | RGD:1352024 | 6480464 | Quercetin inhibits the reaction [PD168393 results in increased expression of CXCL10 mRNA]; more ... | CTD | PMID:21967610 |
| quercetin | decreases secretion | ISO | RGD:1352024 | 6480464 | Quercetin results in decreased secretion of CXCL10 protein | CTD | PMID:21756928 PMID:21967610 |
| quercetin | decreases expression | ISO | RGD:1352024 | 6480464 | Quercetin results in decreased expression of CXCL10 mRNA | CTD | PMID:21756928 PMID:21967610 |
| quercetin | multiple interactions | ISO | RGD:1352024 | 6480464 | Quercetin inhibits the reaction [[TNF protein co-treated with IFNG protein] results in increased secretion of CXCL10 protein] | CTD | PMID:21756928 |
| quercetin | decreases secretion | ISO | RGD:1352024 | 6480464 | Quercetin results in decreased secretion of CXCL10 protein | CTD | PMID:21756928 |
| quercetin | decreases expression | ISO | RGD:1352024 | 6480464 | Quercetin results in decreased expression of CXCL10 mRNA | CTD | PMID:21756928 |
| quercetin | multiple interactions | ISO | RGD:1550709 | 6480464 | Quercetin inhibits the reaction [TNF protein promotes the reaction [CREBBP protein binds to CXCL10 promoter]]; more ... | CTD | PMID:17449583 |
| quercetin | multiple interactions | ISO | RGD:1352024 | 6480464 | Quercetin inhibits the reaction [S100B protein results in increased expression of CXCL10 mRNA] | CTD | PMID:17103373 |
| quinapril hydrochloride | decreases expression | EXP | | 6480464 | quinapril results in decreased expression of CXCL10 | CTD | PMID:15831368 |
| raloxifene | multiple interactions | ISO | RGD:1550709 | 6480464 | Raloxifene inhibits the reaction [lipopolysaccharide, E. coli 026-B6 results in increased expression of CXCL10 mRNA]; more ... | CTD | PMID:19533603 |
| resveratrol | decreases expression | ISO | RGD:1550709 | 6480464 | resveratrol results in decreased expression of CXCL10 mRNA | CTD | PMID:21189227 |
| resveratrol | decreases expression | ISO | RGD:1550709 | 6480464 | resveratrol results in decreased expression of CXCL10 protein | CTD | PMID:21807089 |
| resveratrol | decreases secretion | ISO | RGD:1352024 | 6480464 | resveratrol results in decreased secretion of CXCL10 protein | CTD | PMID:21756928 PMID:21967610 |
| resveratrol | decreases expression | ISO | RGD:1352024 | 6480464 | resveratrol results in decreased expression of CXCL10 mRNA | CTD | PMID:21756928 PMID:21967610 |
| resveratrol | multiple interactions | ISO | RGD:1352024 | 6480464 | resveratrol inhibits the reaction [PD168393 results in increased expression of CXCL10 mRNA]; more ... | CTD | PMID:21967610 |
| resveratrol | decreases secretion | ISO | RGD:1352024 | 6480464 | resveratrol results in decreased secretion of CXCL10 protein | CTD | PMID:21756928 |
| resveratrol | multiple interactions | ISO | RGD:1352024 | 6480464 | resveratrol inhibits the reaction [[TNF protein co-treated with IFNG protein] results in increased secretion of CXCL10 protein] | CTD | PMID:21756928 |
| resveratrol | decreases expression | ISO | RGD:1352024 | 6480464 | resveratrol results in decreased expression of CXCL10 mRNA | CTD | PMID:21756928 |
| rifampicin | multiple interactions | ISO | RGD:1550709 | 6480464 | [Monocrotaline co-treated with Rifampin co-treated with Phenytoin co-treated with PRKDC] results in increased expression of CXCL10 mRNA | CTD | PMID:21224054 |
| rutin | multiple interactions | ISO | RGD:1352024 | 6480464 | Rutin inhibits the reaction [[TNF protein co-treated with IFNG protein] results in increased secretion of CXCL10 protein] | CTD | PMID:21756928 |
| rutin | decreases secretion | ISO | RGD:1352024 | 6480464 | Rutin results in decreased secretion of CXCL10 protein | CTD | PMID:21756928 PMID:21967610 |
| rutin | decreases expression | ISO | RGD:1352024 | 6480464 | Rutin results in decreased expression of CXCL10 mRNA | CTD | PMID:21756928 PMID:21967610 |
| rutin | decreases expression | ISO | RGD:1352024 | 6480464 | Rutin results in decreased expression of CXCL10 mRNA | CTD | PMID:21756928 |
| rutin | decreases secretion | ISO | RGD:1352024 | 6480464 | Rutin results in decreased secretion of CXCL10 protein | CTD | PMID:21756928 |
| S-nitrosoglutathione | decreases secretion | ISO | RGD:1352024 | 6480464 | S-Nitrosoglutathione results in decreased secretion of CXCL10 protein | CTD | PMID:13678430 |
| sevoflurane | decreases expression | EXP | | 6480464 | sevoflurane results in decreased expression of CXCL10 mRNA | CTD | PMID:15564938 |
| silicon dioxide | increases expression | ISO | RGD:1550709 | 6480464 | Silicon Dioxide results in increased expression of CXCL10 mRNA | CTD | PMID:19073995 |
| silicon dioxide | multiple interactions | ISO | RGD:1550709 | 6480464 | [Gold co-treated with Silicon Dioxide] results in increased secretion of CXCL10 protein | CTD | PMID:22155353 |
| silicon dioxide | increases expression | ISO | RGD:1352024 | 6480464 | Silicon Dioxide results in increased expression of CXCL10 mRNA | CTD | PMID:19428942 |
| simvastatin | multiple interactions | ISO | RGD:1550709 | 6480464 | Simvastatin inhibits the reaction [lipopolysaccharide, E coli O55-B5 results in increased expression of CXCL10 mRNA]; more ... | CTD | PMID:15187114 |
| simvastatin | decreases expression | EXP | | 6480464 | Simvastatin results in decreased expression of CXCL10 mRNA | CTD | PMID:16414398 PMID:22305382 |
| simvastatin | decreases expression | EXP | | 6480464 | Simvastatin results in decreased expression of CXCL10 protein | CTD | PMID:17449418 |
| simvastatin | decreases expression | EXP | | 6480464 | Simvastatin results in decreased expression of CXCL10 mRNA | CTD | PMID:22305382 PMID:16414398 |
| sirolimus | decreases expression | EXP | | 6480464 | Sirolimus results in decreased expression of CXCL10 mRNA | CTD | PMID:21865292 |
| sodium dodecyl sulfate | increases expression | ISO | RGD:1352024 | 6480464 | Sodium Dodecyl Sulfate results in increased expression of CXCL10 mRNA | CTD | PMID:17936526 |
| sterigmatocystin | decreases expression | ISO | RGD:1550709 | 6480464 | Sterigmatocystin results in decreased expression of CXCL10 mRNA | CTD | PMID:19818335 |
| sterigmatocystin | increases expression | ISO | RGD:1550709 | 6480464 | Sterigmatocystin results in increased expression of CXCL10 protein | CTD | PMID:21356202 |
| succimer | multiple interactions | ISO | RGD:1550709 | 6480464 | [Succimer binds to Magnetite Nanoparticles] which results in increased expression of CXCL10 mRNA | CTD | PMID:21641980 |
| sumatriptan | multiple interactions | EXP | | 6480464 | [Naproxen co-treated with Sumatriptan] inhibits the reaction [Capsaicin results in increased expression of CXCL10 protein]; more ... | CTD | PMID:22150557 |
| tacrolimus hydrate | increases expression | EXP | | 6480464 | Tacrolimus results in increased expression of CXCL10 mRNA | CTD | PMID:21865292 |
| tamibarotene | decreases expression | ISO | RGD:1550709 | 6480464 | Am 80 results in decreased expression of CXCL10 mRNA; more ... | CTD | PMID:20861477 |
| tamoxifen | affects expression | ISO | RGD:1550709 | 6480464 | Tamoxifen affects the expression of CXCL10 mRNA | CTD | PMID:20937368 |
| tamoxifen | multiple interactions | ISO | RGD:1550709 | 6480464 | Tamoxifen inhibits the reaction [lipopolysaccharide, E. coli 026-B6 results in increased expression of CXCL10 mRNA]; more ... | CTD | PMID:19533603 |
| taurocholic acid | increases expression | ISO | RGD:1550709 | 6480464 | Taurocholic Acid results in increased expression of CXCL10 mRNA | CTD | PMID:21224055 |
| tert-butyl hydroperoxide | increases expression | ISO | RGD:1550709 | 6480464 | tert-Butylhydroperoxide results in increased expression of CXCL10 mRNA | CTD | PMID:15003993 |
| testosterone | increases expression | ISO | RGD:1550709 | 6480464 | Testosterone results in increased expression of CXCL10 mRNA | CTD | PMID:15788153 |
| tetrachloromethane | increases expression | ISO | RGD:1550709 | 6480464 | Carbon Tetrachloride results in increased expression of CXCL10 mRNA | CTD | PMID:12500195 |
| tetrachloromethane | increases expression | EXP | | 6480464 | Carbon Tetrachloride results in increased expression of CXCL10 protein | CTD | PMID:12629582 |
| tetrachloromethane | multiple interactions | ISO | RGD:1550709 | 6480464 | FOXF1A protein affects the reaction [Carbon Tetrachloride results in increased expression of CXCL10 mRNA]; more ... | CTD | PMID:12500195 |
| thalidomide | increases expression | ISO | RGD:1550709 | 6480464 | Thalidomide results in increased expression of CXCL10 | CTD | PMID:17089043 |
| thioacetamide | increases expression | EXP | | 6480464 | Thioacetamide results in increased expression of CXCL10 mRNA | CTD | PMID:16337175 |
| titanium dioxide | increases expression | ISO | RGD:1352024 | 6480464 | titanium dioxide results in increased expression of CXCL10 mRNA | CTD | PMID:19695317 |
| titanium dioxide | increases expression | ISO | RGD:1550709 | 6480464 | titanium dioxide results in increased expression of CXCL10 mRNA | CTD | PMID:21259345 |
| toluene 2,4-diisocyanate | increases expression | ISO | RGD:1550709 | 6480464 | Toluene 2,4-Diisocyanate results in increased expression of CXCL10 mRNA | CTD | PMID:19647056 |
| trans-resveratrol | decreases expression | ISO | RGD:1550709 | 6480464 | resveratrol results in decreased expression of CXCL10 mRNA | CTD | PMID:21189227 |
| trans-resveratrol | decreases expression | ISO | RGD:1550709 | 6480464 | resveratrol results in decreased expression of CXCL10 protein | CTD | PMID:21807089 |
| trans-resveratrol | decreases secretion | ISO | RGD:1352024 | 6480464 | resveratrol results in decreased secretion of CXCL10 protein | CTD | PMID:21756928 PMID:21967610 |
| trans-resveratrol | decreases expression | ISO | RGD:1352024 | 6480464 | resveratrol results in decreased expression of CXCL10 mRNA | CTD | PMID:21756928 PMID:21967610 |
| trans-resveratrol | multiple interactions | ISO | RGD:1352024 | 6480464 | resveratrol inhibits the reaction [PD168393 results in increased expression of CXCL10 mRNA]; more ... | CTD | PMID:21967610 |
| trans-resveratrol | decreases secretion | ISO | RGD:1352024 | 6480464 | resveratrol results in decreased secretion of CXCL10 protein | CTD | PMID:21756928 |
| trans-resveratrol | multiple interactions | ISO | RGD:1352024 | 6480464 | resveratrol inhibits the reaction [[TNF protein co-treated with IFNG protein] results in increased secretion of CXCL10 protein] | CTD | PMID:21756928 |
| trans-resveratrol | decreases expression | ISO | RGD:1352024 | 6480464 | resveratrol results in decreased expression of CXCL10 mRNA | CTD | PMID:21756928 |
| trimellitic anhydride | increases expression | EXP | | 6480464 | trimellitic anhydride results in increased expression of CXCL10 mRNA | CTD | PMID:21893156 |
| troglitazone | increases expression | ISO | RGD:1352024 | 6480464 | troglitazone results in increased expression of CXCL10 mRNA | CTD | PMID:19631733 |
| ursodeoxycholic acid | increases expression | EXP | | 6480464 | Ursodeoxycholic Acid results in increased expression of CXCL10 mRNA | CTD | PMID:15885361 |
| valproic acid | increases expression | EXP | | 6480464 | Valproic Acid results in increased expression of CXCL10 mRNA | CTD | PMID:17202759 |
| valsartan | multiple interactions | ISO | RGD:1550709 | 6480464 | valsartan inhibits the reaction [AGT protein results in increased expression of CXCL10 protein]; more ... | CTD | PMID:18716376 |
| zinc protoporphyrin | multiple interactions | ISO | RGD:1550709 | 6480464 | zinc protoporphyrin inhibits the reaction [ADIPOQ protein inhibits the reaction [Lipopolysaccharides results in increased expression of CXCL10 mRNA]] | CTD | PMID:20861358 |